Table 1.
Before Matching | After Matching | |||||
---|---|---|---|---|---|---|
No Comorbidities (n = 2329) | Cancer History (n = 121) | P-value | No Comorbidities (n = 100) | Cancer History (n = 100) | P-value | |
Gender (n, %) | ||||||
Male | 1050 (45.08%) | 403 (47.93%) | 0.5745 | 48 (48.00%) | 48 (48.00%) | 1 |
Female | 1279 (54.92%) | 231 (50.55%) | 52 (52.00%) | 52 (52.00%) | ||
Age (mean, range) | ||||||
58.75 [15.0,90.0] | 66.50 [27.0,84.0] | <0.0001 | 65.98 [31.0,85.0] | 66.42 [27.0,83.0] | 0.5829 | |
Race (n, %) | ||||||
White | 1959 (84.11%) | 105 (86.78%) | 0.0849 | 91 (91.00%) | 87 (87.00%) | 0.1189 |
Non-White | 370 (15.89%) | 16 (13.22%) | 9 (9.00%) | 13 (13.00%) | ||
BMI (mean, range) | ||||||
29.26 [15.0, 54.4] | 30.50 [13.64, 56.58] | 0.2957 | 28.92 [19.75, 54.4] | 28.58 [18.6,41.75] | 0.93 | |
Tobacco use (n, %) | ||||||
333 (14.30%) | 5 (4.13%) | 0.0005 | 2 (2.00%) | 2 (2.00%) | 1 | |
Insurance type (n, %) | ||||||
Private | 1329 (57.1%) | 43 (35.5%) | <0.0001 | 35 (35.0%) | 35 (35.0%) | 1 |
Public | 1000 (42.9%) | 78 (64.5%) | 65 (65.0%) | 65 (65.0%) | ||
Prior surgery (mean, range) | ||||||
0.52 [0,11] | 0.92 [0,17] | 0.0004 | 0.65 [0,7] | 0.87 [0,17] | 0.90 | |
Prior surgery 30D (mean, range) | ||||||
0.03 [0,3] | 0.02 [0,1] | 0.668 | 0.03 [0,3] | 0.02 [0,1] | 1 | |
ASA score (mean, range) | ||||||
2.24 [1.0,4.0] | 2.48 [2.0,3.0] | <0.0001 | 2.45 [2.0,3.0] | 2.45 [2.0,3.0] | 1 |